Skip to main navigation Skip to search Skip to main content

Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models

  • Kei Kawaguchi
  • , Kentaro Igarashi
  • , Shukuan Li
  • , Qinghong Han
  • , Yuying Tan
  • , Kentaro Miyake
  • , Tasuku Kiyuna
  • , Masuyo Miyake
  • , Takashi Murakami
  • , Bartosz Chmielowski
  • , Scott D. Nelson
  • , Tara A. Russell
  • , Sarah M. Dry
  • , Yunfeng Li
  • , Michiaki Unno
  • , Fritz C. Eilber
  • , Robert M. Hoffman

Research output: Contribution to journal › Article › peer-review

43   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Keyphrases